Arno Hartmann

Valley Forge Pharmaceuticals, Inc. develops ophthalmic pharmaceuticals. It is an early stage ophthalmic pharmaceutical company focused on preventing the development of myopia in children and utilizing proprietary pharmaceutical drugs to control abnormal ocular development. The company is headquartered in Irvine, CA.

Credit Suisse AG is an investment management firm headquartered in Zurich, Switzerland. The firm was founded in 1856 and was acquired by UBS Group AG (SWX: UBSG) from Credit Suisse Group AG in 2023. Credit Suisse manages global and regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals worldwide. They also offer private banking and wealth management, investment banking, and corporate and business support services.

Deka Immobilien GmbH engages in the real estate business. It focuses on the acquisition and sale of real estate, including the leasing and management of other properties. The firm also develops fund products. The company was founded in 1966 and is headquartered in Frankfurt, Germany.

Part of LVM Landwirtschaftlicher Versicherungsverein Münster AG, Allianz Vermoegens Bank AG is an international commercial bank. The company is based in Augsburg, Germany. Allianz Vermoegens Bank was acquired by LVM Landwirtschaftlicher Versicherungsverein Münster AG from Allianz SE on May 24, 2002.

KfW IPEX-Bank GmbH provides project, corporate, trade and export finance services. It offers medium to long-term financing solutions to support the German and European economy. The firm finances economic and social infrastructure in Europe, helps to secure the supply of raw materials and supports the realization of environmental and climate protection projects - all over the world. It finances for ships, aircraft and railroad vehicles as well as for investments in the expansion of airports and seaports. The firm provides tailor-made financing solutions for energy and environmental protection projects. The company was founded in 1948 and is headquartered in Frankfurt, Germany.

Evotape SpA manufactures and markets adhesive products. The firm produces packaging, filament and strapping, masking and paper, specialty, printed version and appliances tapes. The company was founded in 1950 and is headquartered in San Pietro Mosezzo, Italy.

Beteiligungsgesellschaft Sachsen-Anhalt mbH is a private equity/ venture capital firm founded in 1996. The firm is headquartered in Magedeburg.

BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million.

Part of Bellevue Group AG, Biotech Ventures GP Ltd. is a venture capital fund. The company is based in St. Peter Port, UK.

SGL Carbon GmbH manufactures products made from carbon, graphite, and composite materials. The company is headquartered in Meitingen, Germay.

Adria Airways Slovenski Letalski Prevoznik doo operates charter and scheduled flights. It offers weekly flights to various scheduled destinations in Europe and also operates outgoing and incoming seasonal charter flights to destinations including Greece, Spain, Turkey and Tunisia. The firm provides services including rent a car, hotel reservation and bus transfers to and from Ljubljana airport on routes from Zagreb. The company was founded in 1961 and is headquartered in Brnik, Slovenia.

Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom.

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.

Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993.

Part of SGL Carbon SE, SGL CARBON Japan Ltd. is a specialist for graphite and fiber composite materials. The company is based in Chiba, Japan. The Japanese company offers innovative and reliable solutions along the entire value chain.

SGL Process Technology Pte Ltd. operates as a holding company with interest in manufacturing carbon-fiber based products. The company is headquartered in Singapore.

Part of SGL Carbon SE, SGL CARBON Far East Ltd. is a Chinese company that supplies graphite products. The company is based in Shanghai, China.

Part of Pfeiffer HandelsgmbH, ZIP Warenhandel AG operates grocery stores. The company is based in Vienna, Austria. ZIP Warenhandel was acquired by Pfeiffer HandelsgmbH from BOW Beteiligungs GmbH on December 31, 2014.

bmp Ventures /Venture Capital/ (bmp Ventures) is the venture capital arm of bmp Ventures AG. It was founded by Oliver Borrmann in 1997. The firm is headquartered in Berlin, Germany, with another German office located in Magdeburg.

4k Invest International Ltd is a private equity firm founded in the year 2013. Headquarter in Germany.

Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland.

Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021.